Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1096/FJ.202100349R | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Knockout of the chloride channel protein 2 (CLC-2; CLCN2) results in fast progressing blindness in mice. Retinal Pigment Epithelium (RPE) and photoreceptors undergo, in parallel, rapid, and profound morphological changes and degeneration. Immunohistochemistry and electron microscopy of the outer retina and electroretinography of the CLC-2 KO mouse demonstrated normal morphology at postnatal day 2, followed by drastic changes in RPE and photoreceptor morphology and loss of vision during the first postnatal month. To investigate whether the RPE or the photoreceptors are the primary cause of the degeneration, we injected lentiviruses carrying HA-tagged CLC-2 with an RPE-specific promotor in the subretinal space of CLC-2-KO mice at the time of eye opening. As expected, CLC-2-HA was expressed exclusively in RPE; strikingly, this procedure rescued the degeneration of both RPE and photoreceptors. Light response in transduced eyes was also recovered. Only a fraction of RPE was transduced with the lentivirus; however, the entire RPE monolayer appears healthy, even the RPE cells not expressing the CLC-2-HA. Surprisingly, in contrast with previous physiological observations that postulate that CLC-2 has a basolateral localization in RPE, our immunofluorescence experiments demonstrated CLC-2 has an apical distribution, facing the subretinal space and the photoreceptor outer segments. Our findings suggest that CLC-2 does not play the postulated role in fluid transport at the basolateral membrane. Rather, they suggest that CLC-2 performs a critical homeostatic role in the subretinal compartment involving a chloride regulatory mechanism that is critical for the survival of both RPE and photoreceptors.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Hanke-Gogokhia, Christin | Mujer |
YALE UNIV - Estados Unidos
Yale School of Medicine - Estados Unidos |
| 2 | Lehmann, Guillermo L. | Hombre |
Regeneron Pharmaceut Inc - Estados Unidos
Regeneron Pharmaceuticals, Inc. - Estados Unidos |
| 3 | Benedicto, Ignacio | Hombre |
Ctr Nacl Invest Cardiovasc CNIC - España
Centro Nacional de Investigaciones Cardiovasculares Carlos III - España |
| 4 | De la Fuente-Ortega, E. | Hombre |
Universidad Católica del Norte - Chile
|
| 5 | Arshavsky, Vadim Y. | Hombre |
Duke Univ - Estados Unidos
Duke University School of Medicine - Estados Unidos |
| 6 | Schreiner, Ryan | Hombre |
Weill Cornell Med - Estados Unidos
Weill Cornell Medicine - Estados Unidos |
| 7 | Rodriguez-Boulan, Enrique | Hombre |
Weill Cornell Med - Estados Unidos
Weill Cornell Medicine - Estados Unidos |
| Fuente |
|---|
| National Institutes of Health |
| Ministerio de Ciencia e Innovación |
| Instituto de Salud Carlos III |
| Comunidad de Madrid |
| National Institute of General Medical Sciences |
| Duke University |
| Centro Nacional de Investigaciones Cardiovasculares |
| Research to Prevent Blindness |
| National Eye Institute |
| Pro CNIC Foundation |
| Ministerio de Ciencia e Innovaci?n |
| Dyson Foundation |
| Ministerio de Ciencia e Innovacion (MICINN) |
| MINECO | Instituto de Salud Carlos III (ISCIII) |
| New York State Stem Cell Science (NYSTEM) |
| Weill Cornell Medicine |
| HHS | NIH | National Institute of General Medical Sciences (NIGMS) |
| HHS | NIH | National Eye Institute (NEI) |
| New York State Stem Cell Science |
| Agradecimiento |
|---|
| HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY08538; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM34107; New York State Stem Cell Science (NYSTEM), Grant/Award Number: C32596GG; Comunidad de Madrid, Grant/Award Number: 2017-T1/BMD--5247; MINECO | Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovacion (MICINN); Weill Cornell Medicine, Grant/Award Number: EY005722 |
| We thank Ying Hao of the Duke Eye Center Electron Microscopy Core Facility for her technical assistance, Patrick Zager for his technical assistance in maintaining mouse colony, Paulo S Caceres for his technical assistance of lentivirus preparation, and Diego Gravotta for scientific input. Funding for this study was provided by National Institutes of Health grants EY08538 and GM34107, as well as the NYSTEM contract C32596GG (E.R‐B), I.B. was supported by the Comunidad Autónoma de Madrid (grant 2017‐T1/BMD‐5247); additional grant support from the Research to Prevent Blindness and Dyson Foundation to the Ophthalmology department. Further, the CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation. This work was supported by Visual Function Core at Weill Cornell Medicine and the Core grant EY005722 at Duke University. |